Xiao Ying Meng
Director/Miembro de la Junta en BMC MEDICAL CO., LTD. .
Perfil
Xiao Ying Meng is currently the Director at BMC Medical Co. Ltd.
since 2019 and the Non-Executive Director at TYK Medicines, Inc. since 2021.
Previously, she worked as a Member-Supervisory Board at Chengdu Bright Eye Hospital Co., Ltd.
from 2018 to 2022.
Dr. Meng holds a doctorate degree from The Pennsylvania State University, an undergraduate degree from Nanjing University, and a graduate degree from Nanjing University.
Cargos activos de Xiao Ying Meng
| Empresas | Cargo | Inicio |
|---|---|---|
| BMC MEDICAL CO., LTD. | Director/Miembro de la Junta | 01/12/2019 |
TYK Medicines, Inc.
 TYK Medicines, Inc. Pharmaceuticals: MajorHealth Technology TYK Medicines, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the business of research, development and commercialization of pharmaceutical products and differentiated targeted therapies to address unmet medical needs in cancer treatment. The company was founded by Wu Yusheng on November 2, 2017 and is headquartered in Huzhou, China. | Director/Miembro de la Junta | 01/01/2021 |
Antiguos cargos conocidos de Xiao Ying Meng.
| Empresas | Cargo | Fin |
|---|---|---|
| CHENGDU BRIGHT EYE HOSPITAL CO., LTD. | Director/Miembro de la Junta | 10/10/2022 |
Formación de Xiao Ying Meng.
| Nanjing University | Undergraduate Degree |
| The Pennsylvania State University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| CHENGDU BRIGHT EYE HOSPITAL CO., LTD. | Health Services |
| BMC MEDICAL CO., LTD. | Health Technology |
| Empresas privadas | 1 |
|---|---|
TYK Medicines, Inc.
TYK Medicines, Inc. Pharmaceuticals: MajorHealth Technology TYK Medicines, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the business of research, development and commercialization of pharmaceutical products and differentiated targeted therapies to address unmet medical needs in cancer treatment. The company was founded by Wu Yusheng on November 2, 2017 and is headquartered in Huzhou, China. | Health Technology |
- Bolsa de valores
- Insiders
- Xiao Ying Meng
